Within three years of Treatment with Vytorin there is some increase in cancer reported in SEAS trial. I doubt this is true and if so this drug should be labeled a carcinogen..Read this special article reported in NEJM>>
A resource for Internal Medicine Trainees
www.flickr.com
|
September 5, 2008
Diseño por Free CSS Templates | A Blogger por Blog and Web